Contec Medical Systems Co.,Ltd (SHE:300869)
China
· Delayed Price · Currency is CNY 12.76
+0.01 (0.08%)
Apr 24, 2025, 2:45 PM CST
SHE:300869 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | 459.31 | 742.65 | 708.68 | 904.84 | 1,396 | 382.58 | Upgrade
|
| Other Revenue | 4.25 | 4.25 | 3.43 | 3.87 | 4.79 | 4.67 | Upgrade
|
| Revenue | 463.56 | 746.9 | 712.11 | 908.71 | 1,401 | 387.25 | Upgrade
|
| Revenue Growth (YoY) | -46.54% | 4.88% | -21.63% | -35.15% | 261.84% | 6.78% | Upgrade
|
| Cost of Revenue | 268.85 | 359.82 | 382.12 | 476.88 | 591.54 | 207.5 | Upgrade
|
| Gross Profit | 194.71 | 387.08 | 330 | 431.83 | 809.69 | 179.74 | Upgrade
|
| Selling, General & Admin | 127.22 | 155.58 | 122.4 | 95.53 | 92.05 | 76.04 | Upgrade
|
| Research & Development | 114.22 | 110.6 | 93.25 | 66.06 | 48.74 | 40.57 | Upgrade
|
| Other Operating Expenses | 4.25 | -14.44 | 3.78 | -2.84 | -9.23 | -0.35 | Upgrade
|
| Operating Expenses | 246.18 | 250.71 | 221.45 | 159.13 | 132.61 | 117.5 | Upgrade
|
| Operating Income | -51.47 | 136.38 | 108.55 | 272.7 | 677.08 | 62.24 | Upgrade
|
| Interest Expense | -45.1 | -45.1 | -19.08 | -2.86 | -2.42 | -0.04 | Upgrade
|
| Interest & Investment Income | 23.23 | 92.65 | 92.23 | 68.64 | 34.79 | 10.78 | Upgrade
|
| Currency Exchange Gain (Loss) | -2.95 | -2.95 | -13.31 | 60.92 | -13.73 | 3.58 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.37 | -2.23 | -1.5 | -0.94 | -1.52 | -0.54 | Upgrade
|
| EBT Excluding Unusual Items | -77.66 | 178.75 | 166.89 | 398.45 | 694.2 | 76.03 | Upgrade
|
| Gain (Loss) on Sale of Investments | 49.52 | 2.02 | 46.64 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.1 | -0.07 | -0.26 | -0.04 | -0 | 0 | Upgrade
|
| Asset Writedown | -0.27 | - | -0.01 | -0.02 | -0 | -0 | Upgrade
|
| Other Unusual Items | 5.42 | 5.42 | 6.14 | 9.61 | 21.27 | 5.88 | Upgrade
|
| Pretax Income | -22.88 | 186.13 | 219.39 | 407.99 | 715.47 | 81.91 | Upgrade
|
| Income Tax Expense | -3.43 | 20.36 | 23.19 | 55.64 | 102.08 | 8.12 | Upgrade
|
| Net Income | -19.45 | 165.77 | 196.2 | 352.35 | 613.4 | 73.78 | Upgrade
|
| Net Income to Common | -19.45 | 165.77 | 196.2 | 352.35 | 613.4 | 73.78 | Upgrade
|
| Net Income Growth | - | -15.51% | -44.32% | -42.56% | 731.37% | 18.94% | Upgrade
|
| Shares Outstanding (Basic) | 405 | 404 | 400 | 402 | 374 | 369 | Upgrade
|
| Shares Outstanding (Diluted) | 405 | 414 | 409 | 402 | 374 | 369 | Upgrade
|
| Shares Change (YoY) | -0.09% | 1.39% | 1.73% | 7.43% | 1.39% | 1.10% | Upgrade
|
| EPS (Basic) | -0.05 | 0.41 | 0.49 | 0.88 | 1.64 | 0.20 | Upgrade
|
| EPS (Diluted) | -0.05 | 0.40 | 0.48 | 0.88 | 1.64 | 0.20 | Upgrade
|
| EPS Growth | - | -16.67% | -45.26% | -46.53% | 720.00% | 17.65% | Upgrade
|
| Free Cash Flow | 9.39 | 150.28 | 22.21 | -101.66 | 509.06 | 42.79 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.36 | 0.05 | -0.25 | 1.36 | 0.12 | Upgrade
|
| Dividend Per Share | 0.300 | 0.300 | 0.125 | 0.300 | 0.250 | - | Upgrade
|
| Dividend Growth | 140.00% | 140.00% | -58.33% | 20.00% | - | - | Upgrade
|
| Gross Margin | 42.00% | 51.82% | 46.34% | 47.52% | 57.78% | 46.42% | Upgrade
|
| Operating Margin | -11.10% | 18.26% | 15.24% | 30.01% | 48.32% | 16.07% | Upgrade
|
| Profit Margin | -4.20% | 22.19% | 27.55% | 38.77% | 43.78% | 19.05% | Upgrade
|
| Free Cash Flow Margin | 2.02% | 20.12% | 3.12% | -11.19% | 36.33% | 11.05% | Upgrade
|
| EBITDA | -21.26 | 161.77 | 127.51 | 290.34 | 692.25 | 67.27 | Upgrade
|
| EBITDA Margin | -4.58% | 21.66% | 17.91% | 31.95% | 49.40% | 17.37% | Upgrade
|
| D&A For EBITDA | 30.21 | 25.39 | 18.96 | 17.64 | 15.17 | 5.02 | Upgrade
|
| EBIT | -51.47 | 136.38 | 108.55 | 272.7 | 677.08 | 62.24 | Upgrade
|
| EBIT Margin | -11.10% | 18.26% | 15.24% | 30.01% | 48.32% | 16.07% | Upgrade
|
| Effective Tax Rate | - | 10.94% | 10.57% | 13.64% | 14.27% | 9.92% | Upgrade
|
| Revenue as Reported | 463.56 | 746.9 | 712.11 | - | 1,401 | 387.25 | Upgrade
|
| Advertising Expenses | - | 8.32 | 3.8 | 6.21 | 2.26 | 5.4 | Upgrade
|
Updated Oct 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.